HEADER CELL ADHESION/TRANSCRIPTION 24-JAN-08 3C2G TITLE CRYSTAL COMPLEX OF SYS-1/POP-1 AT 2.5A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SYS-1 PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ARMADILLO DOMAIN (UNP RESIDUES 180 - 798); COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: POP-1 8-RESIDUE PEPTIDE; COMPND 8 CHAIN: C, D; COMPND 9 FRAGMENT: BETA-CATENIN BINDING DOMAIN (UNP RESIDUES 8 - 15); COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAENORHABDITIS ELEGANS; SOURCE 3 GENE: SYS-1; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: CAENORHABDITIS ELEGANS; SOURCE 10 GENE: POP-1; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 13 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 14 EXPRESSION_SYSTEM_PLASMID: PGEX4T-1 KEYWDS BETA-CATENIN, PHYLOGENY, SYS-1, POP-1, CAENORHABDITIS ELEGANS, KEYWDS 2 DEVELOPMENTAL PROTEIN, DNA-BINDING, NUCLEUS, CELL ADHESION- KEYWDS 3 TRANSCRIPTION COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.LIU,B.T.PHILLIPS,M.F.AMAYA,J.KIMBLE,W.XU REVDAT 3 25-OCT-17 3C2G 1 REMARK REVDAT 2 24-FEB-09 3C2G 1 VERSN REVDAT 1 20-MAY-08 3C2G 0 JRNL AUTH J.LIU,B.T.PHILLIPS,M.F.AMAYA,J.KIMBLE,W.XU JRNL TITL THE C. ELEGANS SYS-1 PROTEIN IS A BONA FIDE BETA-CATENIN. JRNL REF DEV.CELL V. 14 751 2008 JRNL REFN ISSN 1534-5807 JRNL PMID 18477457 JRNL DOI 10.1016/J.DEVCEL.2008.02.015 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.MISKOWSKI,Y.LI,J.KIMBLE REMARK 1 TITL A BETA-CATENIN IDENTIFIED BY FUNCTIONAL RATHER THAN SEQUENCE REMARK 1 TITL 2 CRITERIA AND ITS ROLE IN WNT/MAPK SIGNALING. REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 121 761 2005 REMARK 1 REFN ISSN 0092-8674 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.R.KIDD III,J.A.MISKOWSKI,K.R.SIEGFRIED,H.SAWA,J.KIMBLE REMARK 1 TITL THE SYS-1 GENE AND SEXUAL DIMORPHISM DURING GONADOGENESIS IN REMARK 1 TITL 2 CAENORHABDITIS ELEGANS. REMARK 1 REF DEV.BIOL. V. 230 61 2001 REMARK 1 REFN ISSN 0012-1606 REMARK 1 REFERENCE 3 REMARK 1 AUTH B.T.PHILLIPS,A.R.KIDD III,R.KING,J.HARDIN,J.KIMBLE REMARK 1 TITL RECIPROCAL ASYMMETRY OF SYS-1/BETA-CATENIN AND POP-1/TCF REMARK 1 TITL 2 CONTROLS ASYMMETRIC DIVISIONS IN CAENORHABDITIS ELEGANS. REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 104 3231 2007 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 4 REMARK 1 AUTH S.HUANG,P.SHETTY,S.M.ROBERTSON,R.LIN REMARK 1 TITL BINARY CELL FATE SPECIFICATION DURING C. ELEGANS REMARK 1 TITL 2 EMBRYOGENESIS DRIVEN BY REITERATED RECIPROCAL ASYMMETRY OF REMARK 1 TITL 3 TCF POP-1 AND ITS COACTIVATOR BETA-CATENIN SYS-1. REMARK 1 REF DEVELOPMENT V. 134 2685 2007 REMARK 1 REFN ISSN 0950-1991 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 75483 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3763 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3894 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 68.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE SET COUNT : 198 REMARK 3 BIN FREE R VALUE : 0.3250 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9885 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.68 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.74000 REMARK 3 B22 (A**2) : 0.89000 REMARK 3 B33 (A**2) : 0.86000 REMARK 3 B12 (A**2) : 1.65000 REMARK 3 B13 (A**2) : 0.24000 REMARK 3 B23 (A**2) : -0.60000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.314 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.253 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.174 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.633 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.903 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 10110 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 13757 ; 1.155 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1242 ; 4.903 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 443 ;40.779 ;24.086 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1739 ;17.012 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 64 ;14.897 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1601 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7564 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4612 ; 0.206 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 7124 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 220 ; 0.138 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 49 ; 0.169 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.158 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 6471 ; 1.159 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 10209 ; 1.886 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4094 ; 2.430 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3548 ; 3.744 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 5 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 180 A 219 6 REMARK 3 1 B 180 B 219 6 REMARK 3 2 A 225 A 590 6 REMARK 3 2 B 225 B 590 6 REMARK 3 3 A 600 A 628 6 REMARK 3 3 B 600 B 628 6 REMARK 3 4 A 631 A 734 6 REMARK 3 4 B 631 B 734 6 REMARK 3 5 A 742 A 792 6 REMARK 3 5 B 742 B 792 6 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 LOOSE POSITIONAL 1 A (A): 3262 ; 0.320 ; 5.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 3262 ; 2.190 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3C2G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000046256. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9792 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 75516 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE, DM 6.0 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES, 0.6 M NA/K TARTRATE, 20 REMARK 280 MM GLYCINE AND 5MM DTT, PH 6.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1190 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1250 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 630 REMARK 465 ASN B 596 REMARK 465 GLY B 597 REMARK 465 GLU B 598 REMARK 465 GLY B 630 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 184 CG CD OE1 NE2 REMARK 470 GLN A 201 CG CD OE1 NE2 REMARK 470 ASP A 216 CG OD1 OD2 REMARK 470 ARG A 287 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 288 CG CD OE1 OE2 REMARK 470 GLN A 292 CG CD OE1 NE2 REMARK 470 LYS A 308 CG CD CE NZ REMARK 470 GLU A 333 CG CD OE1 OE2 REMARK 470 LYS A 334 CG CD CE NZ REMARK 470 GLU A 346 CG CD OE1 OE2 REMARK 470 GLN A 359 CG CD OE1 NE2 REMARK 470 GLU A 431 CG CD OE1 OE2 REMARK 470 THR A 594 OG1 CG2 REMARK 470 ASN A 596 CG OD1 ND2 REMARK 470 GLU A 598 CG CD OE1 OE2 REMARK 470 GLU A 629 CG CD OE1 OE2 REMARK 470 ASP A 632 CG OD1 OD2 REMARK 470 GLU A 667 CG CD OE1 OE2 REMARK 470 ASN A 738 CG OD1 ND2 REMARK 470 GLU A 774 CG CD OE1 OE2 REMARK 470 LYS A 786 CG CD CE NZ REMARK 470 ASN A 798 CG OD1 ND2 REMARK 470 GLN B 184 CG CD OE1 NE2 REMARK 470 ASP B 216 CG OD1 OD2 REMARK 470 LYS B 217 CG CD CE NZ REMARK 470 ASP B 222 CG OD1 OD2 REMARK 470 ASN B 225 CG OD1 ND2 REMARK 470 GLN B 247 CG CD OE1 NE2 REMARK 470 ARG B 287 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 288 CG CD OE1 OE2 REMARK 470 ASN B 289 CG OD1 ND2 REMARK 470 GLN B 292 CG CD OE1 NE2 REMARK 470 LYS B 308 CG CD CE NZ REMARK 470 GLU B 333 CG CD OE1 OE2 REMARK 470 GLU B 338 CG CD OE1 OE2 REMARK 470 GLN B 359 CG CD OE1 NE2 REMARK 470 LYS B 569 CG CD CE NZ REMARK 470 THR B 594 OG1 CG2 REMARK 470 PRO B 595 CG CD REMARK 470 THR B 599 OG1 CG2 REMARK 470 GLU B 629 CG CD OE1 OE2 REMARK 470 ASP B 632 CG OD1 OD2 REMARK 470 GLU B 667 CG CD OE1 OE2 REMARK 470 LYS B 719 CG CD CE NZ REMARK 470 GLU B 774 CG CD OE1 OE2 REMARK 470 LYS B 786 CG CD CE NZ REMARK 470 GLU B 797 CG CD OE1 OE2 REMARK 470 GLU C 9 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 595 C - N - CA ANGL. DEV. = 12.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 380 76.29 -113.73 REMARK 500 GLU A 598 42.90 -97.76 REMARK 500 THR A 599 94.35 -67.17 REMARK 500 ASP A 632 90.41 -63.28 REMARK 500 ASN A 690 116.46 -162.08 REMARK 500 CYS A 730 106.34 -35.13 REMARK 500 PHE B 218 -16.53 69.94 REMARK 500 ALA B 219 -61.78 -18.43 REMARK 500 ARG B 287 -59.51 -137.07 REMARK 500 ASN B 332 108.65 -54.77 REMARK 500 ASP B 463 26.39 81.96 REMARK 500 ASN B 546 33.94 75.04 REMARK 500 PRO B 593 107.36 -39.08 REMARK 500 CYS B 628 124.97 -32.80 REMARK 500 CYS B 730 111.54 -39.73 REMARK 500 ASN B 738 42.82 -95.52 REMARK 500 PHE C 13 68.45 -105.59 REMARK 500 PHE D 13 69.00 -107.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MSE B 200 GLN B 201 149.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3C2H RELATED DB: PDB DBREF 3C2G A 180 798 UNP Q9XVI2 Q9XVI2_CAEEL 180 798 DBREF 3C2G B 180 798 UNP Q9XVI2 Q9XVI2_CAEEL 180 798 DBREF 3C2G C 7 14 UNP Q10666 POP1_CAEEL 8 15 DBREF 3C2G D 7 14 UNP Q10666 POP1_CAEEL 8 15 SEQRES 1 A 619 MSE ASN ILE THR GLN ALA ALA GLU GLN ALA ILE ARG LEU SEQRES 2 A 619 TRP PHE ASN THR PRO ASP PRO MSE GLN ARG LEU HIS MSE SEQRES 3 A 619 ALA LYS THR ILE ARG THR TRP ILE ARG GLN ASP LYS PHE SEQRES 4 A 619 ALA GLN VAL ASP GLN ALA ASN MSE PRO ASN CYS VAL GLN SEQRES 5 A 619 GLN ILE LEU ASN ILE ILE TYR ASP GLY LEU LYS PRO GLN SEQRES 6 A 619 PRO VAL GLN LEU PRO ILE SER TYR TYR ALA GLN LEU TRP SEQRES 7 A 619 TYR ASN LEU LEU ASP ILE LEU ARG ARG PHE THR PHE LEU SEQRES 8 A 619 PRO ILE ILE SER PRO TYR ILE HIS GLN VAL VAL GLN MSE SEQRES 9 A 619 PHE CYS PRO ARG GLU ASN GLY PRO GLN ASP PHE ARG GLU SEQRES 10 A 619 LEU ILE CYS ASN LEU ILE SER LEU ASN TRP GLN LYS ASP SEQRES 11 A 619 PRO HIS MSE LYS HIS CYS ALA ASN GLN VAL PHE GLN ILE SEQRES 12 A 619 PHE ASN CYS ILE ILE MSE GLY VAL LYS ASN GLU LYS LEU SEQRES 13 A 619 ARG THR GLU PHE ALA GLN HIS LEU LYS PHE GLU LYS LEU SEQRES 14 A 619 VAL GLY THR LEU SER GLU TYR PHE ASN PRO GLN VAL HIS SEQRES 15 A 619 PRO GLY MSE ILE ASN PRO ALA ILE PHE ILE ILE PHE ARG SEQRES 16 A 619 PHE ILE ILE SER LYS ASP THR ARG LEU LYS ASP TYR PHE SEQRES 17 A 619 ILE TRP ASN ASN ASN PRO HIS ASP GLN PRO PRO PRO PRO SEQRES 18 A 619 THR GLY LEU ILE ILE LYS LEU ASN ALA VAL MSE ILE GLY SEQRES 19 A 619 SER TYR ARG LEU ILE ALA GLY GLN ASN PRO GLU THR LEU SEQRES 20 A 619 PRO GLN ASN PRO GLU LEU ALA HIS LEU ILE GLN VAL ILE SEQRES 21 A 619 ILE ARG THR PHE ASP LEU LEU GLY LEU LEU LEU HIS ASP SEQRES 22 A 619 SER ASP ALA ILE ASP GLY PHE VAL ARG SER ASP GLY VAL SEQRES 23 A 619 GLY ALA ILE THR THR VAL VAL GLN TYR PRO ASN ASN ASP SEQRES 24 A 619 LEU ILE ARG ALA GLY CYS LYS LEU LEU LEU GLN VAL SER SEQRES 25 A 619 ASP ALA LYS ALA LEU ALA LYS THR PRO LEU GLU ASN ILE SEQRES 26 A 619 LEU PRO PHE LEU LEU ARG LEU ILE GLU ILE HIS PRO ASP SEQRES 27 A 619 ASP GLU VAL ILE TYR SER GLY THR GLY PHE LEU SER ASN SEQRES 28 A 619 VAL VAL ALA HIS LYS GLN HIS VAL LYS ASP ILE ALA ILE SEQRES 29 A 619 ARG SER ASN ALA ILE PHE LEU LEU HIS THR ILE ILE SER SEQRES 30 A 619 LYS TYR PRO ARG LEU ASP GLU LEU THR ASP ALA PRO LYS SEQRES 31 A 619 ARG ASN ARG VAL CYS GLU ILE ILE CYS ASN CYS LEU ARG SEQRES 32 A 619 THR LEU ASN ASN PHE LEU MSE MSE TRP ILE PRO THR PRO SEQRES 33 A 619 ASN GLY GLU THR LYS THR ALA GLY PRO ASN GLU LYS GLN SEQRES 34 A 619 GLN VAL CYS LYS PHE ILE GLU ILE ASP ILE LEU LYS LYS SEQRES 35 A 619 LEU MSE SER CYS LEU SER CYS GLU GLY MSE ASP THR PRO SEQRES 36 A 619 GLY LEU LEU GLU LEU ARG SER THR ILE LEU ARG SER PHE SEQRES 37 A 619 ILE LEU LEU LEU ARG THR PRO PHE VAL PRO LYS ASP GLY SEQRES 38 A 619 VAL LEU ASN VAL ILE ASP GLU ASN ARG LYS GLU ASN LEU SEQRES 39 A 619 ILE GLY HIS ILE CYS ALA ALA TYR SER TRP VAL PHE ARG SEQRES 40 A 619 GLN PRO ASN ASN THR ARG THR GLN SER THR LYS GLN GLN SEQRES 41 A 619 LEU VAL GLU ARG THR ILE SER LEU LEU LEU VAL LEU MSE SEQRES 42 A 619 GLU GLN CYS GLY ALA GLU LYS GLU VAL ALA GLN TYR SER SEQRES 43 A 619 TYR SER ILE ASP CYS PRO LEU ASN LEU LEU ASN GLY ASN SEQRES 44 A 619 GLN VAL LYS PRO THR PHE ILE HIS ASN VAL LEU VAL VAL SEQRES 45 A 619 CYS ASP LYS ILE LEU GLU HIS CYS PRO THR ARG ALA ASP SEQRES 46 A 619 ILE TRP THR ILE ASP ARG PRO MSE LEU GLU GLY LEU THR SEQRES 47 A 619 ASN HIS ARG ASN SER ASP ILE ALA LYS ALA ALA ASN SER SEQRES 48 A 619 LEU LEU SER ARG PHE PRO GLU ASN SEQRES 1 B 619 MSE ASN ILE THR GLN ALA ALA GLU GLN ALA ILE ARG LEU SEQRES 2 B 619 TRP PHE ASN THR PRO ASP PRO MSE GLN ARG LEU HIS MSE SEQRES 3 B 619 ALA LYS THR ILE ARG THR TRP ILE ARG GLN ASP LYS PHE SEQRES 4 B 619 ALA GLN VAL ASP GLN ALA ASN MSE PRO ASN CYS VAL GLN SEQRES 5 B 619 GLN ILE LEU ASN ILE ILE TYR ASP GLY LEU LYS PRO GLN SEQRES 6 B 619 PRO VAL GLN LEU PRO ILE SER TYR TYR ALA GLN LEU TRP SEQRES 7 B 619 TYR ASN LEU LEU ASP ILE LEU ARG ARG PHE THR PHE LEU SEQRES 8 B 619 PRO ILE ILE SER PRO TYR ILE HIS GLN VAL VAL GLN MSE SEQRES 9 B 619 PHE CYS PRO ARG GLU ASN GLY PRO GLN ASP PHE ARG GLU SEQRES 10 B 619 LEU ILE CYS ASN LEU ILE SER LEU ASN TRP GLN LYS ASP SEQRES 11 B 619 PRO HIS MSE LYS HIS CYS ALA ASN GLN VAL PHE GLN ILE SEQRES 12 B 619 PHE ASN CYS ILE ILE MSE GLY VAL LYS ASN GLU LYS LEU SEQRES 13 B 619 ARG THR GLU PHE ALA GLN HIS LEU LYS PHE GLU LYS LEU SEQRES 14 B 619 VAL GLY THR LEU SER GLU TYR PHE ASN PRO GLN VAL HIS SEQRES 15 B 619 PRO GLY MSE ILE ASN PRO ALA ILE PHE ILE ILE PHE ARG SEQRES 16 B 619 PHE ILE ILE SER LYS ASP THR ARG LEU LYS ASP TYR PHE SEQRES 17 B 619 ILE TRP ASN ASN ASN PRO HIS ASP GLN PRO PRO PRO PRO SEQRES 18 B 619 THR GLY LEU ILE ILE LYS LEU ASN ALA VAL MSE ILE GLY SEQRES 19 B 619 SER TYR ARG LEU ILE ALA GLY GLN ASN PRO GLU THR LEU SEQRES 20 B 619 PRO GLN ASN PRO GLU LEU ALA HIS LEU ILE GLN VAL ILE SEQRES 21 B 619 ILE ARG THR PHE ASP LEU LEU GLY LEU LEU LEU HIS ASP SEQRES 22 B 619 SER ASP ALA ILE ASP GLY PHE VAL ARG SER ASP GLY VAL SEQRES 23 B 619 GLY ALA ILE THR THR VAL VAL GLN TYR PRO ASN ASN ASP SEQRES 24 B 619 LEU ILE ARG ALA GLY CYS LYS LEU LEU LEU GLN VAL SER SEQRES 25 B 619 ASP ALA LYS ALA LEU ALA LYS THR PRO LEU GLU ASN ILE SEQRES 26 B 619 LEU PRO PHE LEU LEU ARG LEU ILE GLU ILE HIS PRO ASP SEQRES 27 B 619 ASP GLU VAL ILE TYR SER GLY THR GLY PHE LEU SER ASN SEQRES 28 B 619 VAL VAL ALA HIS LYS GLN HIS VAL LYS ASP ILE ALA ILE SEQRES 29 B 619 ARG SER ASN ALA ILE PHE LEU LEU HIS THR ILE ILE SER SEQRES 30 B 619 LYS TYR PRO ARG LEU ASP GLU LEU THR ASP ALA PRO LYS SEQRES 31 B 619 ARG ASN ARG VAL CYS GLU ILE ILE CYS ASN CYS LEU ARG SEQRES 32 B 619 THR LEU ASN ASN PHE LEU MSE MSE TRP ILE PRO THR PRO SEQRES 33 B 619 ASN GLY GLU THR LYS THR ALA GLY PRO ASN GLU LYS GLN SEQRES 34 B 619 GLN VAL CYS LYS PHE ILE GLU ILE ASP ILE LEU LYS LYS SEQRES 35 B 619 LEU MSE SER CYS LEU SER CYS GLU GLY MSE ASP THR PRO SEQRES 36 B 619 GLY LEU LEU GLU LEU ARG SER THR ILE LEU ARG SER PHE SEQRES 37 B 619 ILE LEU LEU LEU ARG THR PRO PHE VAL PRO LYS ASP GLY SEQRES 38 B 619 VAL LEU ASN VAL ILE ASP GLU ASN ARG LYS GLU ASN LEU SEQRES 39 B 619 ILE GLY HIS ILE CYS ALA ALA TYR SER TRP VAL PHE ARG SEQRES 40 B 619 GLN PRO ASN ASN THR ARG THR GLN SER THR LYS GLN GLN SEQRES 41 B 619 LEU VAL GLU ARG THR ILE SER LEU LEU LEU VAL LEU MSE SEQRES 42 B 619 GLU GLN CYS GLY ALA GLU LYS GLU VAL ALA GLN TYR SER SEQRES 43 B 619 TYR SER ILE ASP CYS PRO LEU ASN LEU LEU ASN GLY ASN SEQRES 44 B 619 GLN VAL LYS PRO THR PHE ILE HIS ASN VAL LEU VAL VAL SEQRES 45 B 619 CYS ASP LYS ILE LEU GLU HIS CYS PRO THR ARG ALA ASP SEQRES 46 B 619 ILE TRP THR ILE ASP ARG PRO MSE LEU GLU GLY LEU THR SEQRES 47 B 619 ASN HIS ARG ASN SER ASP ILE ALA LYS ALA ALA ASN SER SEQRES 48 B 619 LEU LEU SER ARG PHE PRO GLU ASN SEQRES 1 C 8 GLY ASP GLU VAL LYS VAL PHE ARG SEQRES 1 D 8 GLY ASP GLU VAL LYS VAL PHE ARG MODRES 3C2G MSE A 180 MET SELENOMETHIONINE MODRES 3C2G MSE A 200 MET SELENOMETHIONINE MODRES 3C2G MSE A 205 MET SELENOMETHIONINE MODRES 3C2G MSE A 226 MET SELENOMETHIONINE MODRES 3C2G MSE A 283 MET SELENOMETHIONINE MODRES 3C2G MSE A 312 MET SELENOMETHIONINE MODRES 3C2G MSE A 328 MET SELENOMETHIONINE MODRES 3C2G MSE A 364 MET SELENOMETHIONINE MODRES 3C2G MSE A 411 MET SELENOMETHIONINE MODRES 3C2G MSE A 589 MET SELENOMETHIONINE MODRES 3C2G MSE A 590 MET SELENOMETHIONINE MODRES 3C2G MSE A 623 MET SELENOMETHIONINE MODRES 3C2G MSE A 631 MET SELENOMETHIONINE MODRES 3C2G MSE A 712 MET SELENOMETHIONINE MODRES 3C2G MSE A 772 MET SELENOMETHIONINE MODRES 3C2G MSE B 180 MET SELENOMETHIONINE MODRES 3C2G MSE B 200 MET SELENOMETHIONINE MODRES 3C2G MSE B 205 MET SELENOMETHIONINE MODRES 3C2G MSE B 226 MET SELENOMETHIONINE MODRES 3C2G MSE B 283 MET SELENOMETHIONINE MODRES 3C2G MSE B 312 MET SELENOMETHIONINE MODRES 3C2G MSE B 328 MET SELENOMETHIONINE MODRES 3C2G MSE B 364 MET SELENOMETHIONINE MODRES 3C2G MSE B 411 MET SELENOMETHIONINE MODRES 3C2G MSE B 589 MET SELENOMETHIONINE MODRES 3C2G MSE B 590 MET SELENOMETHIONINE MODRES 3C2G MSE B 623 MET SELENOMETHIONINE MODRES 3C2G MSE B 631 MET SELENOMETHIONINE MODRES 3C2G MSE B 712 MET SELENOMETHIONINE MODRES 3C2G MSE B 772 MET SELENOMETHIONINE HET MSE A 180 8 HET MSE A 200 8 HET MSE A 205 8 HET MSE A 226 8 HET MSE A 283 8 HET MSE A 312 8 HET MSE A 328 8 HET MSE A 364 8 HET MSE A 411 8 HET MSE A 589 8 HET MSE A 590 8 HET MSE A 623 8 HET MSE A 631 8 HET MSE A 712 8 HET MSE A 772 8 HET MSE B 180 8 HET MSE B 200 8 HET MSE B 205 8 HET MSE B 226 8 HET MSE B 283 8 HET MSE B 312 8 HET MSE B 328 8 HET MSE B 364 8 HET MSE B 411 8 HET MSE B 589 8 HET MSE B 590 8 HET MSE B 623 8 HET MSE B 631 8 HET MSE B 712 8 HET MSE B 772 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 30(C5 H11 N O2 SE) FORMUL 5 HOH *72(H2 O) HELIX 1 1 ASN A 181 TRP A 193 1 13 HELIX 2 2 PHE A 194 THR A 196 5 3 HELIX 3 3 ASP A 198 LYS A 217 1 20 HELIX 4 4 ASP A 222 ALA A 224 5 3 HELIX 5 5 ASN A 225 LYS A 242 1 18 HELIX 6 6 PRO A 249 LEU A 270 1 22 HELIX 7 7 PRO A 271 PRO A 275 5 5 HELIX 8 8 TYR A 276 MSE A 283 1 8 HELIX 9 9 ASP A 293 ILE A 302 1 10 HELIX 10 10 SER A 303 ASP A 309 5 7 HELIX 11 11 MSE A 312 VAL A 330 1 19 HELIX 12 12 ASN A 332 LYS A 344 1 13 HELIX 13 13 PHE A 345 GLU A 354 1 10 HELIX 14 14 TYR A 355 ASN A 357 5 3 HELIX 15 15 HIS A 361 ASN A 366 5 6 HELIX 16 16 PRO A 367 SER A 378 1 12 HELIX 17 17 ASP A 380 ASN A 390 1 11 HELIX 18 18 GLY A 402 ALA A 419 1 18 HELIX 19 19 ASN A 422 GLN A 428 5 7 HELIX 20 20 ASN A 429 LEU A 450 1 22 HELIX 21 21 ASP A 452 SER A 462 1 11 HELIX 22 22 ASP A 463 VAL A 472 1 10 HELIX 23 23 ASN A 476 SER A 491 1 16 HELIX 24 24 ALA A 493 LYS A 498 5 6 HELIX 25 25 ASN A 503 HIS A 515 1 13 HELIX 26 26 ASP A 517 VAL A 532 1 16 HELIX 27 27 LYS A 535 SER A 545 1 11 HELIX 28 28 ASN A 546 LYS A 557 1 12 HELIX 29 29 ARG A 560 LEU A 564 5 5 HELIX 30 30 ASP A 566 MSE A 589 1 24 HELIX 31 31 MSE A 590 ILE A 592 5 3 HELIX 32 32 GLY A 603 LYS A 612 1 10 HELIX 33 33 GLU A 615 CYS A 628 1 14 HELIX 34 34 GLY A 635 ARG A 652 1 18 HELIX 35 35 GLY A 660 VAL A 664 5 5 HELIX 36 36 ASN A 672 GLN A 687 1 16 HELIX 37 37 THR A 693 CYS A 715 1 23 HELIX 38 38 ALA A 717 TYR A 724 1 8 HELIX 39 39 CYS A 730 ASN A 736 5 7 HELIX 40 40 LYS A 741 CYS A 759 1 19 HELIX 41 41 THR A 761 TRP A 766 1 6 HELIX 42 42 ASP A 769 ASN A 778 1 10 HELIX 43 43 ASN A 781 SER A 793 1 13 HELIX 44 44 ASN B 181 TRP B 193 1 13 HELIX 45 45 PHE B 194 THR B 196 5 3 HELIX 46 46 ASP B 198 LYS B 217 1 20 HELIX 47 47 ASN B 225 LYS B 242 1 18 HELIX 48 48 PRO B 249 LEU B 270 1 22 HELIX 49 49 ILE B 273 PRO B 275 5 3 HELIX 50 50 TYR B 276 PHE B 284 1 9 HELIX 51 51 ASP B 293 ILE B 302 1 10 HELIX 52 52 SER B 303 ASP B 309 5 7 HELIX 53 53 MSE B 312 VAL B 330 1 19 HELIX 54 54 ASN B 332 LYS B 344 1 13 HELIX 55 55 PHE B 345 GLU B 354 1 10 HELIX 56 56 TYR B 355 ASN B 357 5 3 HELIX 57 57 HIS B 361 ASN B 366 5 6 HELIX 58 58 PRO B 367 SER B 378 1 12 HELIX 59 59 ASP B 380 ASN B 390 1 11 HELIX 60 60 GLY B 402 ALA B 419 1 18 HELIX 61 61 ASN B 422 GLN B 428 5 7 HELIX 62 62 ASN B 429 LEU B 450 1 22 HELIX 63 63 ASP B 452 SER B 462 1 11 HELIX 64 64 ASP B 463 VAL B 472 1 10 HELIX 65 65 ASN B 476 SER B 491 1 16 HELIX 66 66 ALA B 493 LYS B 498 5 6 HELIX 67 67 ASN B 503 HIS B 515 1 13 HELIX 68 68 ASP B 517 ALA B 533 1 17 HELIX 69 69 LYS B 535 SER B 545 1 11 HELIX 70 70 ASN B 546 TYR B 558 1 13 HELIX 71 71 ARG B 560 LEU B 564 5 5 HELIX 72 72 ASP B 566 MSE B 589 1 24 HELIX 73 73 GLY B 603 CYS B 611 1 9 HELIX 74 74 LYS B 612 ILE B 614 5 3 HELIX 75 75 GLU B 615 CYS B 628 1 14 HELIX 76 76 GLY B 635 THR B 653 1 19 HELIX 77 77 GLY B 660 VAL B 664 5 5 HELIX 78 78 ASN B 672 ARG B 686 1 15 HELIX 79 79 THR B 693 CYS B 715 1 23 HELIX 80 80 ALA B 717 SER B 725 1 9 HELIX 81 81 CYS B 730 GLY B 737 5 8 HELIX 82 82 LYS B 741 CYS B 759 1 19 HELIX 83 83 THR B 761 TRP B 766 1 6 HELIX 84 84 ASP B 769 LEU B 776 1 8 HELIX 85 85 THR B 777 HIS B 779 5 3 HELIX 86 86 ASN B 781 SER B 793 1 13 LINK C MSE A 180 N ASN A 181 1555 1555 1.33 LINK C PRO A 199 N MSE A 200 1555 1555 1.33 LINK C MSE A 200 N GLN A 201 1555 1555 1.33 LINK C HIS A 204 N MSE A 205 1555 1555 1.33 LINK C MSE A 205 N ALA A 206 1555 1555 1.33 LINK C ASN A 225 N MSE A 226 1555 1555 1.33 LINK C MSE A 226 N PRO A 227 1555 1555 1.35 LINK C GLN A 282 N MSE A 283 1555 1555 1.34 LINK C MSE A 283 N PHE A 284 1555 1555 1.33 LINK C HIS A 311 N MSE A 312 1555 1555 1.33 LINK C MSE A 312 N LYS A 313 1555 1555 1.33 LINK C ILE A 327 N MSE A 328 1555 1555 1.33 LINK C MSE A 328 N GLY A 329 1555 1555 1.33 LINK C GLY A 363 N MSE A 364 1555 1555 1.34 LINK C MSE A 364 N ILE A 365 1555 1555 1.33 LINK C VAL A 410 N MSE A 411 1555 1555 1.33 LINK C MSE A 411 N ILE A 412 1555 1555 1.33 LINK C LEU A 588 N MSE A 589 1555 1555 1.33 LINK C MSE A 589 N MSE A 590 1555 1555 1.33 LINK C MSE A 590 N TRP A 591 1555 1555 1.33 LINK C LEU A 622 N MSE A 623 1555 1555 1.33 LINK C MSE A 623 N SER A 624 1555 1555 1.33 LINK C MSE A 631 N ASP A 632 1555 1555 1.34 LINK C LEU A 711 N MSE A 712 1555 1555 1.33 LINK C MSE A 712 N GLU A 713 1555 1555 1.33 LINK C PRO A 771 N MSE A 772 1555 1555 1.33 LINK C MSE A 772 N LEU A 773 1555 1555 1.33 LINK C MSE B 180 N ASN B 181 1555 1555 1.33 LINK C PRO B 199 N MSE B 200 1555 1555 1.32 LINK C MSE B 200 N GLN B 201 1555 1555 1.32 LINK C HIS B 204 N MSE B 205 1555 1555 1.33 LINK C MSE B 205 N ALA B 206 1555 1555 1.33 LINK C ASN B 225 N MSE B 226 1555 1555 1.33 LINK C MSE B 226 N PRO B 227 1555 1555 1.36 LINK C GLN B 282 N MSE B 283 1555 1555 1.34 LINK C MSE B 283 N PHE B 284 1555 1555 1.33 LINK C HIS B 311 N MSE B 312 1555 1555 1.33 LINK C MSE B 312 N LYS B 313 1555 1555 1.33 LINK C ILE B 327 N MSE B 328 1555 1555 1.33 LINK C MSE B 328 N GLY B 329 1555 1555 1.33 LINK C GLY B 363 N MSE B 364 1555 1555 1.33 LINK C MSE B 364 N ILE B 365 1555 1555 1.33 LINK C VAL B 410 N MSE B 411 1555 1555 1.33 LINK C MSE B 411 N ILE B 412 1555 1555 1.33 LINK C LEU B 588 N MSE B 589 1555 1555 1.32 LINK C MSE B 589 N MSE B 590 1555 1555 1.33 LINK C MSE B 590 N TRP B 591 1555 1555 1.33 LINK C LEU B 622 N MSE B 623 1555 1555 1.33 LINK C MSE B 623 N SER B 624 1555 1555 1.33 LINK C MSE B 631 N ASP B 632 1555 1555 1.34 LINK C LEU B 711 N MSE B 712 1555 1555 1.33 LINK C MSE B 712 N GLU B 713 1555 1555 1.33 LINK C PRO B 771 N MSE B 772 1555 1555 1.33 LINK C MSE B 772 N LEU B 773 1555 1555 1.33 CRYST1 84.969 85.343 93.657 65.22 78.08 83.02 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011769 -0.001441 -0.002077 0.00000 SCALE2 0.000000 0.011805 -0.005240 0.00000 SCALE3 0.000000 0.000000 0.011939 0.00000 HETATM 1 N MSE A 180 26.037 8.724 24.552 1.00 91.52 N HETATM 2 CA MSE A 180 25.281 9.805 25.255 1.00 92.18 C HETATM 3 C MSE A 180 23.846 9.431 25.600 1.00 89.59 C HETATM 4 O MSE A 180 23.032 9.158 24.714 1.00 89.26 O HETATM 5 CB MSE A 180 25.273 11.093 24.433 1.00 92.13 C HETATM 6 CG MSE A 180 26.448 12.007 24.708 1.00 94.39 C HETATM 7 SE MSE A 180 25.968 13.902 24.571 1.00 97.37 SE HETATM 8 CE MSE A 180 25.383 13.970 22.692 1.00 96.96 C